Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway
Keyword(s):
2009 ◽
Vol 284
(22)
◽
pp. 15277-15288
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 278
(15)
◽
pp. 12834-12845
◽
Keyword(s):